Although plasma levels of aldosterone are elevated and expression of MR is increased in obesity and diabetes3,8,9 mechanisms by which aldosterone/MR signaling impact on vascular remodeling and function in these conditions remains unclear. This evidence concerns the gene NR3C2 and obesity due to melanocortin 4 receptor deficiency.